Literature DB >> 11513906

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.

M Davies1, F Hobbs, R Davis, J Kenkre, A K Roalfe, R Hare, D Wosornu, R J Lancashire.   

Abstract

BACKGROUND: Accurate data for prevalence rates for heart failure due to various causes, and for left-ventricular systolic dysfunction in all adults are unavailable. Our aim was to assess prevalence of left-ventricular systolic dysfunction and heart failure in a large representative adult population in England.
METHODS: Of 6286 randomly selected patients aged 45 years and older, 3960 (63%) participated in the study. They came from 16 randomly selected general practices. We assessed patients by history and examination, electrocardiography, and echocardiography. Prevalence of left-ventricular systolic dysfunction (defined as ejection fraction <40%) and heart failure was calculated for the overall population on the basis of strict criteria and, when necessary, adjudication by a panel.
FINDINGS: Left-ventricular systolic dysfunction was diagnosed in 72 (1.8% [95% CI 1.4-2.3]) participants, half of whom had no symptoms. Borderline left-ventricular function (ejection fraction 40-50%) was seen in 139 patients (3.5% [3.0-4.1]). Definite heart failure was seen in 92 (2.3%, [1.9-2.8]) and was associated with an ejection fraction of less than 40% in 38 (41%) patients, atrial fibrillation in 30 (33%), and valve disease in 24 (26%). Probable heart failure was seen in a further 32 (0.8% [0.6-1.1]) patients. In total, 124 (3.1% [2.6-3.7]) patients aged 45 years or older had definite or probable heart failure.
INTERPRETATION: Heart failure is often misdiagnosed or underdiagnosed in primary care. Our results suggest that assessment of left-ventricular function in patients with suspected heart failure could lead to more effective diagnosis and treatment of this disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11513906     DOI: 10.1016/s0140-6736(01)05620-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  120 in total

Review 1.  The role of brain natriuretic peptide in population screening.

Authors:  Liselotte N Dyrbye; Margaret M Redfield
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

Review 2.  Unmet need for diagnosis of heart failure: the view from primary care.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 3.  Contemporary management of heart failure in clinical practice.

Authors:  J G F Cleland
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

4.  Valuable insights from morbidity coding in primary care.

Authors:  Tom Fahey
Journal:  BMJ       Date:  2004-04-23

5.  Clinical burden and health service challenges of chronic heart failure.

Authors:  F D Richard Hobbs
Journal:  Br J Gen Pract       Date:  2010-08       Impact factor: 5.386

Review 6.  Early detection of myocardial dysfunction and heart failure.

Authors:  Geoffrey de Couto; Maral Ouzounian; Peter P Liu
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

7.  Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.

Authors:  M P Sanz; L Borque; A Rus; B Vicente; Y Ramírez; L Lasa
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

8.  Survival differences between heart failure in general practices and in hospitals.

Authors:  O Wendelboe Nielsen; J Hilden; T McDonagh; J Fischer Hansen
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

9.  Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study.

Authors:  Amil M Shah; Susan Cheng; Hicham Skali; Justina Wu; Judy R Mangion; Dalane Kitzman; Kunihiro Matsushita; Suma Konety; Kenneth R Butler; Ervin R Fox; Nakela Cook; Hanyu Ni; Josef Coresh; Thomas H Mosley; Gerardo Heiss; Aaron R Folsom; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

10.  Therapies for Preventing Heart Failure.

Authors:  Richard F. Wright
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.